The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The FDA says the okay to use Victoza (liraglutide) in paediatric patients aged 10 or over comes “at a time when an increasing number of children are being diagnosed with this disease.” ...
The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ... single-patient-use pen that delivers doses of 0.6mg, 1.2mg, or 1.8mg in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback